What You Should Know:
- Valerie Health, the AI front office for independent provider groups, today announced a $30 million Series A led by Redpoint Ventures, bringing total funding to $39 million.
- Valerie embeds AI agents with humans-in-the-loop directly inside a clinic’s existing workflows and systems to fully automate rote tasks, including referrals, faxes, and scheduling. This reduces administrative costs by roughly half while improving patient engagement and
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation
What You Should Know:
- Tebra has raised $250M in new equity and debt financing, led by Hildred, to transform its EHR+ platform from a passive "System of Record" into an active "System of Action" using AI.
- The funding will accelerate the rollout of AI tools designed to automate clinical documentation, revenue cycle management, and patient marketing for independent practices. Tebra's goal is to level the playing field for private providers facing burnout and financial pressure
Read More
Why Cardiologists Are Betting $19M on Wearlinq to Fix the “Single-Lead” Problem in Heart Monitoring
What You Should Know:
- Wearlinq has secured $14M in Series A funding (plus $5M in venture debt) to scale its eWave device, the first continuous 6-lead wireless ECG that offers hospital-grade diagnostics in a comfortable wearable led by AIX Ventures with participation from SpringTide and the Berkeley Catalyst Fund.
- The FDA-cleared device solves a critical gap in cardiac care by pairing directly with smartphones to deliver near real-time data, moving beyond the limitations of
Read More
Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know:
- MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on "deep health" solutions that address diseases linked to environmental toxins and synthetic exposures.
- Backed by institutional heavyweights like Industry Ventures and the State of New York, the firm plans to deploy checks ranging from $1 million to $4 million into startups that move beyond symptom management
Read More
Ritten Raises $35M to Scale AI-Powered Behavioral Health Platform
What You Should Know:
- Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35 million USD Series B funding round led by Five Elms Capital with participation from existing investors Threshold Ventures, 8VC, Bienville Capital, and others.
- This investment will support Ritten's expansion across mental health and addiction treatment providers spanning all levels of care.
A Unified Platform Purpose-Built for Behavioral Health
Read More
OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI
What You Should Know:
- Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
- Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s proprietary AI models, which can predict biochemical interactions and design drugs for targets previously considered "undruggable."
- With backing from industry heavyweights like OpenAI and Thrive Capital, Chai is positioning itself
Read More
Auxira Health Raises $7.8M to Solve the Cardiology Shortage with Virtual Clinical Pods
What You Should Know:
- Auxira Health, a virtual cardiology company co-developed by MedStar Health, has secured $7.8M in seed funding to address the growing cardiologist shortage and clinician burnout crisis.
- Unlike standard telehealth platforms, Auxira embeds dedicated "clinical pods" of nurses and advanced practitioners directly into existing practice workflows, training them on-site to ensure seamless integration.
- The funding will fuel the company's expansion,
Read More
Valinor Raises $13M to Predict Clinical Trial Outcomes Using Multi-Omic AI
What You Should Know:
- Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry's most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures.
- The company uses proprietary AI models trained on matched multi-omic samples and clinical outcomes to predict how specific patient populations will respond to new therapies. This "response-first" approach aims to drastically de-risk drug development by identifying responders
Read More
Subsense Raises $10M to Replace Brain Implants with Nasal Nanoparticles
What You Should Know:
- Subsense Inc. has raised an additional $10M, bringing its total funding to $27M, to develop a non-surgical brain-computer interface (BCI) that relies on engineered nanoparticles rather than implanted chips.
- Administered nasally to cross the blood-brain barrier, this technology aims to record and modulate brain activity with high precision without the risks associated with invasive surgery.
- The funding from Golden Falcon Capital
Read More
Accenture Invests in Ryght AI to Accelerate Clinical Trials with Agentic AI and Digital Twins
What You Should Know:
- Accenture has made a strategic investment in Ryght AI through its venture capital arm, aiming to modernize the sluggish clinical trial process. Ryght AI utilizes "agentic AI" and its proprietary AI Site Twin platform to create dynamic digital replicas of research sites, allowing pharmaceutical companies to optimize site selection and patient enrollment.
- The strategic collaboration seeks to remove the manual bottlenecks that delay life-saving therapies,
Read More
